Author

Eva Hernández‐Illán

Hospital Clínic de BarcelonaORCID 0000-0002-4022-0548Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:machine learning (classical)· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Antoni CastellsiD· 2 shared Jordi CampsiD· 2 shared Juan José LozanoiD· 2 shared Elena AsensioiD· 1 shared Ferran NadeuiD· 1 shared Iván ArchillaiD· 1 shared Javier del ReyiD· 1 shared Josep Maria LlovetiD· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Antoni CastellsORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer

Sara Lahoz, Iván Archilla, Elena Asensio, Eva Hernández‐Illán, Queralt Ferrer, Sandra López‐Prades, Ferran Nadeu, Javier del Rey, Rebeca Sanz Pamplona, Juan José Lozano, Antoni Castells, Míriam Cuatrecasas, Jordi Camps

The paper identifies copy-number intratumor heterogeneity as a predictor of relapse in stage II colon cancer, improving risk prediction beyond clinicopathological markers.

bioRxiv · Apr 16, 2021 · PreprintGenomics

CNApp: quantification of genomic copy number alterations in cancer and integrative analysis to unravel clinical implications

Sebastià Franch‐Expósito, Laia Bassaganyas, María Vila-Casadesús, Eva Hernández‐Illán, Roger Esteban-Fabró, Marcos Díaz‐Gay, Juan José Lozano, Antoni Castells, Josep Maria Llovet, Sergi Castellvı́-Bel, Jordi Camps

CNApp quantifies genomic copy number alterations in cancer and integrates them with clinical and molecular data to identify clinical implications.

bioRxiv · Jul 16, 2019 · PreprintGenomics